Clinical Trials List
2025-11-01 - 2030-12-31
Phase III
Recruiting5
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- PO-HUNG LIN Division of Hematology & Oncology
- Jing-Ren Tseng Division of Nuclear Medicine
- I-hung Shao Division of Hematology & Oncology
- 張鈞弼 Division of Radiology
- Hong-Cheng Gan Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- 張境夫 Division of Hematology & Oncology
- See-Tong Pang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yu-De Wang Division of Urology
- Po-Fan Hsieh Division of Urology
- Ching-Chan Lin Division of Hematology & Oncology
- Che-Hung Lin 無
- Chao-Hsiang Chang Division of Urology
- 鄭富銘 Division of Hematology & Oncology
- Wei-Ching Lin Division of Radiology
- Yi-Huei Chang Division of Urology
- Po-Jen Hsiao Division of Urology
- 蔡禮賢 Division of Urology
- Chi-Rei Yang Division of Urology
- 謝德鈞 Division of Nuclear Medicine
- Chi-Ping Huang Division of Urology
- Su-Peng Yeh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Cheng-Kuang Yang Division of Hematology & Oncology
- 梅承恩 Division of Urology
- 張家程
- Chia-Yen Lin Division of Urology
- JU-CHUAN HU
- 楊哲瑞 Division of Urology
- 王樹吉 Division of Urology
- 蔡世傳 Division of Nuclear Medicine
- 楊涵中
- Chuan-Shu Chen
- 賴谷順 Division of Hematology & Oncology
- 裘坤元 Division of Urology
- 林雁婷 Division of Radiology
- Cheng-Che Chen Division of Urology
- Jian-Ri Li Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yuh-Shyan Tsai Division of Urology
- Kuan-Yu Wu Division of Urology
- 戴大堯 Division of Urology
- 鍾秉軒 Division of Hematology & Oncology
- Che-Yuan Hu Division of Urology
- 盧則宏 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
35 participants
-
Global
800 participants